Summary
This article discusses the future of animal testing in light of evolving ethical perspectives and emerging challenges. It explores innovative methods, highlights issues with traditional animal testing, and underscores the limitations of such methods.
The article provides examples of successful alternative methods, focusing on two specific techniques: the use of high-throughput assays to identify high prioritization chemicals for further testing and the development of non-animal alternatives for assessing skin sensitization.
Furthermore, the article delves into the challenges associated with repeat-dose toxicity testing, noting the significant difficulty in developing non-animal alternatives for this purpose. It highlights the progress made in the read-across technique and proof-of-concept projects that have effectively addressed repeat-dose toxicity for substances with existing historical data. Additionally, the article offers solutions for substances lacking such data, including the use of in vitro assays, organoids, and computational simulations.
In its closing paragraphs, the article examines the current status and future prospects of the methods discussed in previous paragraphs. It stresses the importance of persistently employing these methods to achieve the ultimate goal of replacing animal testing. Furthermore, it advocates for ongoing exploration of innovative solutions, especially for new chemical compounds lacking sufficient data.
The article acknowledges the quantity of data already generated and emphasizes its crucial role in facilitating the read-across method. It underscores the significance of collaboration and data sharing across interdisciplinary, intersectional and international collaboration. Lastly, the article calls for industry, academia, and regulatory bodies to adapt to new methodologies, emphasizing the need for innovative regulatory interpretations to transition non-animal methods from a mere supportive role to primary tools in safety assessment.
Cannot be posted